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The commercial samples of aerial parts of Origanum vulgare L. and Ocimum basili-
cum L. (Lamiaceae) were tested for antimicrobial activity. The activity of the extracts 
with different polarity was tested against a panel of microorganisms, including labo-
ratory strain Helicobacter pylori NCTC 12868. The tested extracts showed a moder-
ate activity. The extracts of O. vulgare were more active against bacteria, especially 
against Gram positive bacteria with the minimal inhibitory concentration (MIC) be-
tween 62.5 and 125 µg/mL, than the extracts of O. basilicum which were active 
against Candida albicans (MIC 125 µg/mL). Cyclohexane extract of O. vulgare did 
not show any activity against tested H. pylori, while all other tested extracts were 
active with MICs between 250 µg/mL and 500 µg/mL. Identified and quantified ros-
marinic acid and other polar compounds could be active antibacterial compounds in 
these spices.
Keywords: Origanum vulgare L.; Oci-
mum basilicum L.; antimicrobial activity; 
Helicobacter pylori
Introduction 
Helicobacter pylori is Gram negative bacterium, one of 
the most common pathogens in the human stomach with 
the potential to cause chronic gastritis and peptic ulcer dis-
ease. In addition, persistent infection by H. pylori favours 
the development of gastric cancer [1,2]. Today a strong as-
sociation between H. pylori infection and both cancer de-
velopment and progression is known, and this is the first 
bacterium recognized as a class I carcinogen [3]. Eradica-
tion of H. pylori is successful by using the antibiotic therapy, 
but the resistance to antibiotics is emerging, especially to 
metronidazole and clarithromycin [4,5,6,7]. Natural prod-
ucts could be very useful in the treatment of H. pylori in-
fection, but also as an adjutant to antibiotic therapy. The 
compounds isolated from plants could be safe and effective 
against both antibiotic-resistant and susceptible H. pylori 
strains, and this is the reason why the research in the field 
of natural products is essential.   
The traditional use of plants as medicine provide the ba-
sis for suggesting that essential oils and plant extracts may 
be useful for specific medical conditions. The antimicrobial 
activity of natural compounds is well documented, includ-
ing a few reports on the effects of essential oils against H. 
pylori [8,9,10]. 
The herbs of two aromatic species O. vulgare L. and O. 
basilicum L. (Lamiaceae) are used as spices in everyday 
life, as well as medicine for treating different conditions, in-
cluding respiratory and digestive disorders [11,12]. In Serbi-
an traditional medicine, except for culinary use, O. basilicum 
was used as mild sedative, antihelmintic, and also against 
flatulence or urinary infections, while O. vulgare has a long 
tradition in the treatment of respiratory infections, gastro-
intestinal diseases (particularly diarrhoea) and against in-
flammation of skin and mucous membranes [13]. 
The chemistry of essential oil of O. vulgare and O. basili-
cum and its antimicrobial activity is well studied [14,15], as 
well as the chemistry and activity of different herb extracts 
[16]. Phenolic compounds, phenolic acids and flavonoids 
are major compounds of oregano and basil herb accord-
ing to the literature [11,17-22]. Recent reports have shown 
a very good antimicrobial activity of the essential oils of O. 
vulgare subsp. glandulosum rich in carvacrol, while some 
phenolics isolated from O. vulgare possessed weak to 
moderate anti-viral activity [11,23]. Several reports present-
ed the results of weak or moderate anti-H. pylori activity of 
the essential oil or different extracts of Oregano species 
[8,20,24]. Also, some reports suggested synergistic ef-
fects against H. pylori in vitro of phenolics from oregano 
and cranberry water soluble extracts (0.1 mg of phenolics/
disc) through urease inhibition and disruption of the energy 
production by inhibition of proline dehydrogenase at the 
plasma membrane [25]. 
O. basilicum is also an aromatic plant rich in essential 
oil and phenolic compounds (flavonoids, phenolic acids) 
with known antimicrobial activity. Nakhae et al. (2006) stud-
ied anti-H. pylori activity of O. basilicum extracts using the 
agar-diffusion method, while Castillo-Juárez et al. (2009) 
(ORIGINAL SCIENTIFIC PAPER)
UDC 582.929.4:66.061.34:579.86
*  Author address: Tatjana Kundaković,  Department of Pharmacognosy, Faculty of Pharmacy, 
University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia
E-mail: ktatjana@pharmacy.bg.ac.rs 
The manuscript received: September, 08, 2015.
Paper accepted: October, 07, 2015.
 06 
Advanced technologies 4(2) (2015) 05-10
obtained significant minimal inhibitory concentrations 
(MICs) of O. basilicum extracts of different polarity [26,27].
The aim of this study was to investigate the antimicrobi-
al activity of selected commercial samples of oregano and 
basil, especially against H. pylori, and to quantify the most 
abundant component of the extracts, rosmarinic acid. 
Experimental
Chemicals and reagents
Rosmarinic acid (RA), and standard antibiotics (am-
picillin, amikacin, metronidazol, tetracycline, amoxicillin) 
were purchased from Sigma-Aldrich (St. Louis, MO). All 
organic solvents were HPLC grade and were purchased 
from J.T.Baker (Deventer, The Netherlands). All other rea-
gents for antimicrobial activity testing were: Mueller-Hinton 
broth, antibiotic supplement, Columbia Blood Agar Base 
and CampyGenTM (Oxoid, Thermo Scientific, UK), glycerol 
(Merck, USA), yeast extract and horse blood (Torlak, Bel-
grade, Serbia), casitone (Difco, USA), RPMI-1640 medium 
(Sigma, St. Louis, MO, USA), 10% heat inactivated foetal 
bovine serum FBS (GIBCO, Thermo Fisher Scientific, Life 
Technologies). All other reagents were from Sigma (St. 
Louis, MO).
Plant extract preparation
The commercial samples of aerial parts of O. vulgare 
L. and O. basilicum L. (Lamiaceae) were purchased (Insti-
tute for Medicinal Plant Research “Josif Pančić”, Belgrade) 
and used for the antimicrobial test. The air-dried, powdered 
aerial parts (10 g-basil; 10 g-oregano) were extracted with 
cyclohexane during three days on room temperature (1:5, 
two times, successively). After filtration, the plant material 
was dried and extracted with dichloromethane and metha-
nol using the same procedure. The solvent was evaporated 
under low pressure and dried to obtain C6H12 (0.0817 g), 
CH2Cl2 (0.1153 g) and MeOH extracts (0.3958 g) of O. vul-
gare and C6H12 (0.0946 g), CH2Cl2 (0.1760 g) and MeOH 
extracts of O. basilicum (0.3422 g). The methanol extract 
was used for quantification of rosmarinic acid (RA) and all 
three extracts for antimicrobial analysis.
Quantification of rosmarinic acid in the plant extract
HPLC separation was performed using a Agilent 1100 
Series system equipped with a G-1312A binary pump, a 
G-1328B injector (20 μL loop) and G1315B DAD detec-
tor. The column used was a ZORBAX Eclipse XDB-C18 
(4.6 × 250 nm, 5 µm) and operated at the temperature 
of 25 °C. A gradient elution was performed with solvent A 
(H2O and H3PO4, pH=2.8) and B (solvent A: acetonitrile) as 
follows: 10-25% B (5 min), 25% B isocratic (10 min), 25-
30% B (5 min), 30-50% B (5 min), 50-70% B (5 min), 70-
10% B (5 min) at a flow rate of 0.8 mL/min. The injection 
volume was 20 μL. The presence of RA was identified on 
the bases of its retention time and UV spectra, as well as by 
direct comparison with the standard. Quantification of RA 
was performed under the same condition; detection wave-
length was 320 nm. All chromatographic operations were 
carried out at room temperature. The calibration curve was 
constructed with five concentrations of standard solutions 
of RA. Within the concentration range of 0.100-1 mg/mL, 
the relationship between the peak area of RA was linear 
with a regression equation y = 27071x - 457.5 (x- concen-
tration of RA; y – peak area of RA). The retention time of 
standard substance RA was 18.8 min. The linearity of the 
calibration curve was verified by the correlation coefficient 
(r2 = 0.9998). Each measurement was performed in tripli-
cates. The concentration of 5 mg/mL of the methanol ex-
tract of O. vulgare and O. basilicum in acetonitrile and water 
(40:60, V/V) was used to calculate the amount of RA. 
Antimicrobial activity
For antimicrobial testing, methanol, dichlormethane and 
cyclohexane extracts were used. The screening of antimi-
crobial activity of the tested extracts samples was evaluat-
ed using nine different laboratory strains of bacteria - Gram 
positive: Staphylococcus aureus (ATCC 25923), S. epider-
midis (ATCC 12228), Micrococcus luteus (ATCC 9341), Ba-
cillus subtilis (ATCC 6633), Enterococcus feacalis (ATCC 
29212) and Gram negative: Escherichia coli (ATCC 25922), 
Klebsiella pneumoniae (NCIMB 9111), Pseudomonas aer-
uginosa (ATCC 27853), Salmonella abony (ATCC 13076) 
and one strain of the yeast Candida albicans (ATCC 10231). 
The broth microdilution method was used to determine min-
imal inhibitory concentrations (MICs) of the tested extracts 
according to Clinical and Laboratory Standards Institute 
[28]. These tests were performed in Müller-Hinton broth for 
bacteria and in Sabouraud dextrose broth for Candida. Test 
strains were suspended in medium to give a final density 
of 2.0 x 106 cfu/mL. The samples of the extracts were dis-
solved in dimethylsulfoxide (DMSO) in concentrations of 
1.0 mg/mL. Serial dilutions of the stock solutions in broth 
medium were prepared in a microtitre plate (96 wells). The 
MIC was defined as the lowest concentration of the extract 
at which the microorganism does not demonstrate a visible 
growth. All antimicrobial tests were performed in duplicate 
and two positive growth controls were included. The MICs 
of ampicillin and amikacin were determined in parallel ex-
periments.
Anti-Helicobacter pylori activity
Laboratory strain of H. pylori (NCTC 12868) was used 
as an indicator for the detection of antimicrobial activity of 
plant extracts. H. pylori was maintained at -80 °C in Mueller-
Hinton Broth supplemented with 10% horse blood and 20% 
(v/v) glycerol until required for experiments. Before being 
used, the strain was subcultured twice on Columbia Blood 
Agar Base supplemented with 0.5% (w/V) yeast extract, 
1% (w/V) casitone, 10% (v/v) horse blood and antibiotic 
supplement. Plates were incubated for 72 h at 37 °C un-
der microaerophilic conditions in a jar with CampyGenTM. 
Colonies were suspended in RPMI-1640 medium supple-
mented with 10% heat inactivated foetal bovine serum and 
0.5% yeast extract to achieve the turbidity requested for the 
antimicrobial test. Metronidazol, tetracycline and amoxicil-
lin were used as standard antibiotics.
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Determination of MIC by Agar Dilution Method
Antimicrobial activity of the plant extracts was followed 
on plates prepared as described above. Two-fold dilutions 
of each plant extract were prepared in RPMI-1640 medium. 
The strains were plated on agar plates and 10 µl drops 
of twofold dilutions of the plant extracts were spotted on 
the plates in triplicates. The plates were incubated at 37 °C 
under microaerophilic conditions (CampyGenTM). The 
plates were examined visually after 72 h of incubation. The 
minimal inhibitory concentration was defined as the lowest 
concentration of the extract inhibiting the visible bacterial 
growth. Metronidazol, tetracycline and amoxicillin showed 
ten-fold lower activity than the extracts with MIC values ≤ 
0.625 mg/ml. 
Results and discussion
Determination of rosmarinic acid content
Rosmarinic acid was previously isolated from oregano 
extracts by different authors [11,29,30], and concerned pre-
viously as an important antioxidant and antimicrobial agent. 
Park et al. (2011) determined the content of RA in herb 
extracts of different Lamiaceae species and found that the 
percentage was between 0.22-0.97%, while Shekarchi et 
al. (2012) showed the content of 25.0 ± 0.1 mg/g of dried 
O. vulgare [29,31]. Austrian plants of O. vulgare contained 
from 0.6-37.2 mg/g dry mass, while Lithuanian plants pos-
sessed the maximum value of 9.7 mg/g dry mass in the 
flower extract [32,33]. 
The quantity of RA in different tissues of O. basilicum 
grown in vitro or in hydroponic culture was different. RA 
ranged approximately from 4 to 63 mg/g DW [21] or in 
phenolics rich extracts 3.2 mg/g extract [19]. In commer-
cial samples of methanolic extracts of oregano and basil, 
different concentrations of RA and other phenolics were 
determined after (basil: 14.59-86.01 mg/100 g; oregano: 
2.04-575.80 mg/100 g) [3]. Our results have shown that the 
content of RA in oregano was 14 mg/g and basil 2.4 mg/g. 
Concerning the wide range of previously obtained results, 
commercial samples of oregano and basil were in accord-
ance with literature data.
Antimicrobial activity
Tested extracts showed a moderate antimicrobial ac-
tivity. Their MIC values are presented in Table 1. Antimi-
crobial activity of rosmarinic acid was published before by 
Stanojković et al. (2013) and MIC values for antibacterial 
activity were 0.0125-0.1 mg/mL [34]. Antifungal activity was 
stronger with MICs 0.0125-0.05 mg/mL. Antibiotics were 
more active than the tested extracts. The MIC values of 
antibiotics are presented in Table 2.
The obtained MIC values for bacteria, except H. pylori 
were between 62.5 and 125 µg/mL for O. vulgare extracts, 
and 125 and 250 µg/mL for O. basilicum extracts. The ex-
tracts of O. vulgare were more active against bacteria, es-
pecially against Gram positive bacteria (except B. subtilis) 
than the extracts of O. basilicum which were active against 
C. albicans (MIC 125 µg/mL). Dichlormethane and metha-
nol extracts of O. vulgare were more active against S. typh-
imurium (MIC 62.5 µg/mL) than corresponding extracts of 
O. basilicum (MIC 250 µg/mL). 
Table 1. Antimicrobial activity of tested O. vulgare and O. ba-
silicum extracts (MIC μg/mL)
*OV- O. vulgare extracts; OB – O. basilicum extracts (C-cyclohexane, D- dichlo-
romethane, M-methanol)
Previous studies were focused on the antimicrobial 
activity of essential oils of oregano and basil. A strong 
antimicrobial activity attributed to present phenolic com-
pounds i.e. carvacrol, thymol and linalool [14,15,16,35]. 
There were less researches concerning antimicrobial 
activity of oregano or basil extracts. Because of toxic 
effects of carvacrol and thymol (oregano), and estragol 
(basil) that are concentrated in the essential oils, testing 
of these extracts can have practical application [36].
The recent paper of Martins et al. (2014) showed a 
moderate antibacterial activity of the ethanol extract of 
oregano herb in the concentration of 20 mg/mL against 
Gram negative bacteria E. coli, P. aeruginosa, E. saka-
zakii and P. vulgaris [37]. The other authors showed that 
methanol extract of O. basilicum did not have any anti-
bacterial activity even in the concentrations which were 
higher than 2640 mg/mL [38].
Cyclohexane extract of O. vulgare did not show any 
activity against tested H. pylori, while all other tested ex-
tracts were active with MICs between 250 µg/mL (metha-
nol extract of O. vulgare and dichlormethane extract of O. 
basilicum) and 500 µg/mL (cyclohexane and methanol 
extract of O. basilicum; dichlomethane extract of O. vul-
gare). O. basilicum and O. vulgare extracts were moder-
ate active, with the strongest activity of dichlormethane 
and methanol extracts suggesting that polar compounds 
were the most active compounds. Ethnopharmacologi-
cal survey of anti-H. pylori pylori activity of different aro-
matic plants showed that O. majorana ethanol extract 
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possessed activity against seven clinical isolates of H. 
pylori in the concentration of 250-500 µg/ml [20]. Ohno 
et al. (2003) showed in vitro inhibitory activity against 
H. pylori growth at the concentration of 0.1% (V/V) of O. 
majorana and O. basilicum album essential oils [8]. 
Table 2. Antimicrobial activity of tested antibiotics (MIC μg/mL)
*n.t. – not tested
The relatedness between antimicrobial activity and 
phenolic compounds present in some plants was al-
ready observed when using microorganisms other than 
H. pylori. The results of Chun et al. (2005) showed that 
aqueous (50 mg phenolics per disk) and ethanol extracts 
of cloned O. vulgare against H. pylori ATCC 43504 than 
commercial samples (100 mg of phenolics) [39]. The au-
thors concluded that a higher antioxidant activity as well 
as higher phenolics content could be the reason for anti-
H. pylori activity due to different mechanisms. Methanol 
extracts of O. dictamnus, O. majorana and O. vulgare 
from Greece exhibited a moderate antimicrobial activity 
against 15 clinical isolates of H. pylori with MICs 0.625-5 
mg/mL [24]. Similar results were obtained with O. basili-
cum methanol extract (MIC 2.5-5 mg/mL). Our results for 
O. vulgare extracts could be comparable with the results 
of Mahady et al. (2005) who showed very low MICs in 
vitro of methanol extracts of O. majorana herb and O. 
vulgare against 14 clinical isolates and 1 ATCC strains 
(50-100 µg/mL) [40], because all other authors obtained 
much higher MIC values. 
Different Ocimum species were tested against H. py-
lori and for gastroprotective activity [41,42,43]. MICs of 
the extracts against 4 most sensitive clinical isolates of H. 
pylori were 677 and 729 µg/mL. Very low MICs (31.2 µg/
ml) were obtained for the methanol extract of O. basili-
cum from Mexico [27], and for methanol, n-hexane and 
butanol fraction of O. basilicum methanol extract from 
Iran (39.1, 41 and 117.2 µg/ml), while aqueous fraction 
did not have any activity against tested clinical isolates 
of H. pylori [26]. Our results for tested basil extracts were 
between 250 and 500 µg/mL against standard H. pylori 
strain. It was obvious from the literature that clinical iso-
lates of H. pylori were more sensitive to tested O. basili-
cum and O. vulgare extracts. 
Rosmarinic acid was the major compound in tested 
methanol extracts. A previous study of Lin et al. (2005) 
considered the synergistic effects against H. pylori in vit-
ro of phenolics from oregano and cranberry water soluble 
extracts (0.1 mg of phenolics/disc) through urease inhibi-
tion from one side and disruption of the energy produc-
tion on the other. The inhibition of proline dehydrogenase 
at the plasma membrane was linked with higher-molecu-
lar-weight phenolics from oregano which operated at the 
plasma membrane level and subsequently, upon urease 
inhibition [25]. Also, partial hydrophobicity of phenolics of 
oregano may allow the attachment and inhibition at the 
plasma membrane level.
As a major phenolic in oregano methanol extract, ros-
marinic acid could be involved in exhibited activity. Even 
in the content of RA in oregano 14 mg/g and basil 2.4 
mg/g for commercial samples and with very high anti-
Helicobacter pylori activity, we can conclude that ros-
marinic acid was not the only active compound in the 
tested methanol extracts. Some other compounds were 
probably involved in anti-H. pylori activity.
Conclusion
Origano and basil are very common spices in every 
day diet and could be important in both prevention and 
treatment of many diseases, including bacterial infection. 
As a rich source of phenolic compounds and other sec-
ondary metabolites with antimicrobial activity, they could 
be subjected for further preventive role in H. pylori infec-
tion in vivo, and to chemical structure determination of 
active compounds.   
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ANTIMIKROBNA AKTIVNOST EKSTRAKATA ORIGANA 
(Origanum vulgare L.) I BOSILJKA (Ocimum basilicum L.)
Stanislava Brđanin1, Nemanja Bogdanović1, Marina Kolundžić1, Marina Milenković2, 
Nataša Golić3, Milan Kojić3, Tatjana Kundaković1
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Komercijalni uzorci nadzemnih delova Origanum vulgare L. i Ocimum basilicum 
L. (Lamiaceae) su korišćeni za određivanje antimikrobne aktivnosti. Aktivnost 
ekstrakata različite polarnosti je testirana protiv izabranih mikroorganizama, 
uključujući laboratorijski soj Helicobacter pilori NCTC 12868. Testirani ekstrakti su 
imali umerenu aktivnost. Ekstrakti O. vulgare su bili aktivniji protiv bakterija, poseb-
no Gram pozitivnih bakterija sa minimalnim inhibitornim koncentracijama (MIK) 
između 62,5 i 125 µg/mL, od ekstrakata O. basilicum koji su pokazali aktivnost 
protiv Candida albicans (MIK 125 µg/mL). Cikloheksanski ekstrakt O. vulgare nije 
pokazao antimikrobnu aktivnost na testirani H. pylori, dok su ostali testirani ek-
strakti bili aktivni sa MIK vrednostima između 250 µg/mL i 500 µg/mL. Identifiko-
vana i kvantifikovana ruzmarinska kiselina i druga polarna jedinjenja mogu pred-
stavljati aktivna jedinjenja sa antibakterijskom aktivnošću u ovim začinima. 
Ključne reči: Origanum vulgare L.; Oci-
mum basilicum L.; antimikrobna ak-
tivnost; Helicobacter pylori
(ORIGINALNI NAUČNI RAD) 
UDK  582.929.4:66.061.34:579.86
Izvod
